Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
North Dallas Gazette: Would Senate Passage of ACA Subsidies Band-Aid a Broken System?
One in three Americans cannot afford their prescriptions, noted Merith Basey of Patients for Affordable Drugs, and they pay between 4 and 8 times more than other high-income countries. Many countries negotiate drug prices, noted Basey, though the powerful American pharmaceutical industry has prevented Medicare from negotiating prices for over 20 years despite that they […]
News and Reports
Epoch Times: Botox, 14 Other Drugs to Be Negotiated by Medicare This Year
Merith Basey, CEO of advocacy group Patients for Affordable Drugs, said the negotiation program is effective at lowering prices. “As negotiations continue, millions more people on Medicare stand to benefit,” Basey said in a Jan. 28 statement. “Nobody should have to choose between life-saving drugs and their basic needs.”
News and Reports
India Post News: How Soaring Costs Are Reshaping Health Care Access?
Merith Basey, Executive Director, Patients for Affordable Drugs stated that the persistently high drug prices in the United States are primarily due to pharmaceutical companies maintaining market monopolies through the patent system. Drug prices are entirely set by the pharmaceutical companies themselves, with a lack of government negotiation mechanisms. She pointed out that research shows […]
News and Reports
KTVU Fox: Costs Reshaping Healthcare Forum As ACA Subsidies Expire
The speakers included Stanford University Professor of economics doctor Neil Mahoney and Merith Basey with Patients For Affordable Drugs, who talked about increasing prescription drug prices.
News and Reports
WRTV Indianapolis: Scammers take advantage of popularity of GLP-1 drugs
As the Better Business Bureau tracks complaints about GLP-1-related scams, Patients for Affordable Drugs is tracking GLP-1 prices. The national patient advocacy organization says the injectables are still too costly for many Americans. “The issue is largely driven by the power of the pharmaceutical industry and the monopoly power they have over setting prices,” said […]
News and Reports
Healthcare Finance: Solicitor general weighs in on Supreme Court review of drug price negotiations
On Jan. 1, the first round of negotiated drug prices took effect. Among the drugs targeted in the first round was Farxiga, a drug made by AstraZeneca. CMS selected the 10 drugs in August 2023. The drugs accounted for $50 billion of gross Medicare Part D prescription drug costs between June 2022 and May 2023. […]
News and Reports
Axios: Drug prices to keep rising through Trump's term
Advocacy group Patients for Affordable Drugs said in response to the survey results that the IRA’s reforms are working for seniors. “[T]hat’s exactly why expanding and protecting the law matters,” Alyson Bancroft, director of policy, legislation and alliances, told Axios in an email. Health and Human Services communications director Andrew Nixon told Axios the agency […]
News and Reports
Epoch Times: Lower Prices for 10 Medicare Drugs Now in Effect: What to Know
Merith Basey, CEO for Patients For Affordable Drugs, said the negotiation brought overdue accountability to pharmaceutical manufacturers who have long charged higher prices to U.S. customers than to those in other countries. “This is a historic step, but it cannot be the last,” Basey said in a Jan. 1 statement. “Medicare negotiation must be protected, […]